Medidata announced that its application, myMedidata, has been launched and is designed to be used by patients in clinical trials. The app is a single destination patient portal, allowing them to connect via any online device to learn about, enroll in, and engage in clinical trials.
For trial sponsors, Medidata states that the app can help to expedite the start-up of trials, improve patient experience, help to integrate research into patients’ daily routines, and has been built with feedback from patients.
The company outlines that the app is unified with the Medidata platform, including its Rave EDC (electronic data capture) module, which allows patient input, site-based activities, and behind the scenes data management to operate together.
Sponsors and contract research organization (CRO) partners are able to use the Medidata Designer, a platform configuration tool, that allows them to build and tailor screen templates and visual workflow tools. The Designer tool is managed through drag and drop templates, while also allowing for the background set up of clinical database without custom code.
“Our latest addition to myMedidata brings an innovative app to patients designed in concert with our patient insights team, customer feedback, and the experiences derived from running the world’s biggest DCTs over the last twenty years,” said Matt Noble, senior vice president, Medidata Patient Cloud.
In terms of features, the myMedidata app includes eConsent that allows for patients to watch a study’s eConsent video and review all relevant consent documents. Through the trial life cycle, patients can access their myMedidata accounts to virtually complete any necessary electronic clinical outcome assessment (eCOAs) and patient diaries.
In addition, patients can use web-based, live video conferencing capabilities of the app. myMedidata registries also expands patient participation from a single trial to pre- and post-trial engagement and patient data return, with Medidata stating that this creates a community of educated and engaged patients.
The announcement adds to a number of initiatives that Medidata has launched during the course of 2022. In February, Parexel and Medidata extended their partnership working on decentralized trial solutions. Shortly after, Medidata joined up with Circuit Clinical, allowing the latter company to standardize its decentralized trial offering with Medidata’s Rave and myMedidata technologies.
